Companies: 11,396     total market cap: $149.038 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
โ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Relmada Therapeutics
RLMD
#7766
Rank
$0.44 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
$4.14
Share price
6.15%
Change (1 day)
37.54%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Annual Reports (10-K)

Annual Reports (10-K)Quarterly Reports (10-Q)

Latest form 10-K annual reports for Relmada Therapeutics CIK: 0001553643

Thumbnail Relmada Therapeutics 10-K Annual Report 2025

10-K Annual Report 2025

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-KT Transition Report 2019

10-KT Transition Report 2019

Form: 10-KT
Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2017

10-K Annual Report 2017

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2016

10-K Annual Report 2016

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2015

10-K Annual Report 2015

Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-KT Transition Report 2014

10-KT Transition Report 2014

Form: 10-KT
Language: English

View Annual Report (10-K)
Thumbnail Relmada Therapeutics 10-K Annual Report 2013

10-K Annual Report 2013

Language: English

View Annual Report (10-K)

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com